These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 21716165)
1. Bilateral effect of unilateral ranibizumab in patients with uveitis-related macular edema. Acharya NR; Sittivarakul W; Qian Y; Hong KC; Lee SM Retina; 2011 Oct; 31(9):1871-6. PubMed ID: 21716165 [TBL] [Abstract][Full Text] [Related]
2. Ranibizumab for refractory uveitis-related macular edema. Acharya NR; Hong KC; Lee SM Am J Ophthalmol; 2009 Aug; 148(2):303-309.e2. PubMed ID: 19427988 [TBL] [Abstract][Full Text] [Related]
3. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study. Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142 [TBL] [Abstract][Full Text] [Related]
4. Optical coherence tomography-guided ranibizumab injection for cystoid macular edema in well-controlled uveitis: twelve-month outcomes. Reddy AK; Cabrera M; Yeh S; Davis JL; Albini TA Retina; 2014 Dec; 34(12):2431-8. PubMed ID: 25170857 [TBL] [Abstract][Full Text] [Related]
5. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic interventions for macular diseases show characteristic effects on near and distance visual function. Munk M; Kiss C; Huf W; Sulzbacher F; Bolz M; Sayegh R; Eisenkölbl S; Simader C; Schmidt-Erfurth U Retina; 2013 Oct; 33(9):1915-22. PubMed ID: 23584693 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal ranibizumab for macular edema secondary to central retinal vein occlusion. Risard SM; Pieramici DJ; Rabena MD; Basefsky JC; Avery RL; Castellarin AA; Nasir MA; See RF; Couvillion SS Retina; 2011 Jun; 31(6):1060-7. PubMed ID: 21283055 [TBL] [Abstract][Full Text] [Related]
8. Longer-term outcomes of a prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion. Chang LK; Spaide RF; Klancnik JM; Sorenson J; Slakter JS; Freund KB; Yannuzzi LA; Tseng JJ; Klein R Retina; 2011 May; 31(5):821-8. PubMed ID: 21317833 [TBL] [Abstract][Full Text] [Related]
9. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema. Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study. Mackensen F; Heinz C; Becker MD; Heiligenhaus A Retina; 2008 Jan; 28(1):41-5. PubMed ID: 18185136 [TBL] [Abstract][Full Text] [Related]
11. The effect of fellow eye visual acuity on visual acuity of study eyes receiving ranibizumab for age-related macular degeneration. Zweifel SA; Saroj N; Shapiro H; Freund KB Retina; 2012 Jul; 32(7):1243-9. PubMed ID: 22466461 [TBL] [Abstract][Full Text] [Related]
12. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Nguyen QD; Brown DM; Marcus DM; Boyer DS; Patel S; Feiner L; Gibson A; Sy J; Rundle AC; Hopkins JJ; Rubio RG; Ehrlich JS; Ophthalmology; 2012 Apr; 119(4):789-801. PubMed ID: 22330964 [TBL] [Abstract][Full Text] [Related]
13. Three-year follow-up of a pilot study of ranibizumab combined with proton beam irradiation as treatment for exudative age-related macular degeneration. Park SS; Daftari I; Phillips T; Morse LS Retina; 2012 May; 32(5):956-66. PubMed ID: 22183743 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of ranibizumab in patients with macular edema secondary to central retinal vein occlusion: results from the sham-controlled ROCC study. Kinge B; Stordahl PB; Forsaa V; Fossen K; Haugstad M; Helgesen OH; Seland J; Stene-Johansen I Am J Ophthalmol; 2010 Sep; 150(3):310-4. PubMed ID: 20591399 [TBL] [Abstract][Full Text] [Related]
15. Treatment of macular edema because of occlusive vasculitis with bevacizumab (avastin): efficacy of three consecutive monthly injections. Nuti E; Traversi C; Marigliani D; Balestrazzi A; Alegente M; Martone G; Malandrini A; Romeo N; Mazzotta C; Tosi GM Retina; 2011 Oct; 31(9):1863-70. PubMed ID: 21799465 [TBL] [Abstract][Full Text] [Related]
16. Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials. Varma R; Bressler NM; Suñer I; Lee P; Dolan CM; Ward J; Colman S; Rubio RG; Ophthalmology; 2012 Oct; 119(10):2108-18. PubMed ID: 22817833 [TBL] [Abstract][Full Text] [Related]
17. Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies. Soheilian M; Karimi S; Ramezani A; Peyman GA Retina; 2010 Mar; 30(3):509-15. PubMed ID: 19952986 [TBL] [Abstract][Full Text] [Related]
18. Vision-related function after ranibizumab treatment for diabetic macular edema: results from RIDE and RISE. Bressler NM; Varma R; Suñer IJ; Dolan CM; Ward J; Ehrlich JS; Colman S; Turpcu A; Ophthalmology; 2014 Dec; 121(12):2461-72. PubMed ID: 25148789 [TBL] [Abstract][Full Text] [Related]
19. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Campochiaro PA; Brown DM; Awh CC; Lee SY; Gray S; Saroj N; Murahashi WY; Rubio RG Ophthalmology; 2011 Oct; 118(10):2041-9. PubMed ID: 21715011 [TBL] [Abstract][Full Text] [Related]
20. Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions. Pieramici DJ; Rabena M; Castellarin AA; Nasir M; See R; Norton T; Sanchez A; Risard S; Avery RL Ophthalmology; 2008 Oct; 115(10):e47-54. PubMed ID: 18708258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]